Elevated c-Src tyrosine kinase activity in premalignant epithelia of ulcerative colitis
- PMID: 7509341
- PMCID: PMC293871
- DOI: 10.1172/JCI117000
Elevated c-Src tyrosine kinase activity in premalignant epithelia of ulcerative colitis
Abstract
Ulcerative colitis (UC) is a chronic inflammatory disease of the colon with a high incidence of colon cancer. Dysplasia is a precursor to carcinoma and a predictor of malignant potential; epithelia containing high-grade or severe dysplasia is most likely to develop cancer. The cellular oncogene c-src and its viral homologue v-src (the transforming gene of Rous sarcoma virus) encode 60-kD cytoplasmic, membrane-associated protein tyrosine kinases. For the viral protein or transforming mutants of the cellular protein (Src), a close correlation exists between elevated tyrosine kinase activity and malignant transformation of cells. Previously, we and others observed elevated Src activity in sporadic colon carcinomas and benign adenomas at greatest risk for developing cancer (those with large size, villous architecture, and/or severe dysplasia). Here we report that Src activity and protein abundance are also elevated in neoplastic UC epithelia. Activity is highest in malignant and severely dysplastic epithelia, and 6-10-fold higher in mildly dysplastic than in nondysplastic epithelia. Thus, Src activity is elevated in premalignant UC epithelia, which is at greatest risk for developing cancer. The data suggest that activation of the src proto-oncogene is an early event in the genesis of UC colon cancer.
Similar articles
-
Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.Hepatogastroenterology. 1997 Mar-Apr;44(14):435-40. Hepatogastroenterology. 1997. PMID: 9164515
-
c-src tyrosine kinase activity: a marker of dysplasia in ulcerative colitis.Gastroenterology. 1994 Nov;107(5):1565-6. doi: 10.1016/0016-5085(94)90570-3. Gastroenterology. 1994. PMID: 7523230 No abstract available.
-
Elevated c-yes tyrosine kinase activity in premalignant lesions of the colon.Gastroenterology. 1995 Jan;108(1):117-24. doi: 10.1016/0016-5085(95)90015-2. Gastroenterology. 1995. PMID: 7806032
-
[Precancerous lesions of the colon and rectum].Gan To Kagaku Ryoho. 1984 Jan;11(1):1-9. Gan To Kagaku Ryoho. 1984. PMID: 6364991 Review. Japanese.
-
Diagnostic problems and advances in inflammatory bowel disease.Mod Pathol. 2003 Apr;16(4):347-58. doi: 10.1097/01.MP.0000064746.82024.D1. Mod Pathol. 2003. PMID: 12692200 Review.
Cited by
-
Elevated c-Src is linked to altered cell-matrix adhesion rather than proliferation in KM12C human colorectal cancer cells.Br J Cancer. 2002 Nov 4;87(10):1128-35. doi: 10.1038/sj.bjc.6600594. Br J Cancer. 2002. PMID: 12402152 Free PMC article.
-
The role of Src in solid tumors.Oncologist. 2009 Jul;14(7):667-78. doi: 10.1634/theoncologist.2009-0009. Epub 2009 Jul 6. Oncologist. 2009. PMID: 19581523 Free PMC article. Review.
-
Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab.Oncogene. 2011 Feb 3;30(5):561-74. doi: 10.1038/onc.2010.430. Epub 2010 Oct 18. Oncogene. 2011. PMID: 20956938 Free PMC article.
-
Dok-1 independently attenuates Ras/mitogen-activated protein kinase and Src/c-myc pathways to inhibit platelet-derived growth factor-induced mitogenesis.Mol Cell Biol. 2006 Apr;26(7):2479-89. doi: 10.1128/MCB.26.7.2479-2489.2006. Mol Cell Biol. 2006. PMID: 16537894 Free PMC article.
-
Downregulation of Rap1GAP in human tumor cells alters cell/matrix and cell/cell adhesion.Mol Cell Biol. 2010 Jul;30(13):3262-74. doi: 10.1128/MCB.01345-09. Epub 2010 May 3. Mol Cell Biol. 2010. PMID: 20439492 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous